• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液透析患者中通过定量形态计量学评估的椎体骨折高发率与血管钙化密切相关。

High prevalence of vertebral fractures assessed by quantitative morphometry in hemodialysis patients, strongly associated with vascular calcifications.

机构信息

Aging Section, Consiglio Nazionale delle Ricerche (CNR)-Institute of Neuroscience, Via Giustiniani, 2, 35128, Padua, Italy.

出版信息

Calcif Tissue Int. 2013 Jul;93(1):39-47. doi: 10.1007/s00223-013-9722-x. Epub 2013 Mar 14.

DOI:10.1007/s00223-013-9722-x
PMID:23494409
Abstract

Few studies have provided information on the prevalence of vertebral fractures (VFs) and their risk factors in hemodialysis patients. A multicenter, cross-sectional, observational study was carried out to assess the prevalence of VFs and vascular calcifications (VCs) in 387 hemodialysis patients (mean age 64.2 ± 14.1 years, 63 % males) and in a control group of 51 osteoporotic subjects. Biochemical tests included 25(OH) vitamin D, bone Gla protein (total and undercarboxylated), and total matrix Gla protein. Vertebral quantitative morphometry was carried out centrally for the detection of VF, defined as reduction by ≥20 % of one of the vertebral body dimensions. In the same radiograph, aortic and iliac VC scores were calculated. Prevalence of VF was 55.3 % in hemodialysis patients and 51.0 % in the control group. Multivariate analysis disclosed that male gender (59.8 vs. 47.6 %, p = 0.02; OR = 1.78, 95 % CI 1.15-2.75) and age (mean ± SD 66.7 ± 13.1 vs. 61.0 ± 14.7 years, p < 0.001; OR = 1.03, 95 % CI 1.01-1.05) were significantly associated with VF. The prevalence of aortic VC was significantly higher in hemodialysis patients than in controls (80.6 vs. 68.4 %, p = 0.001). The factors with the strongest association with VC, apart from atrial fibrillation, were serum 25(OH)vitamin D levels below 29 ng/mL for aortic VC (OR = 1.85, 95 % CI 1.04-3.29) and VF both for aortic (OR = 1.77, 95 % CI 1.00-3.14) and iliac (OR = 1.96, 95 % CI 1.27-3.04) VC. In conclusion, the prevalence of VF, especially in males, and VC, in both genders, is high in hemodialysis patients. VF is associated with VC. Vitamin D deficiency is also associated with VC. Further longitudinal studies are warranted to investigate fractures in renal patients.

摘要

很少有研究提供关于血液透析患者椎体骨折(VF)及其危险因素的信息。一项多中心、横断面、观察性研究评估了 387 名血液透析患者(平均年龄 64.2±14.1 岁,63%为男性)和 51 名骨质疏松症患者的 VF 和血管钙化(VC)的发生率。生化检查包括 25(OH)维生素 D、骨 Gla 蛋白(总蛋白和非羧化蛋白)和总基质 Gla 蛋白。通过中央定量形态计量学检测 VF,定义为一个椎体尺寸减少≥20%。在同一张 X 光片上,计算了主动脉和髂骨 VC 评分。血液透析患者 VF 的发生率为 55.3%,对照组为 51.0%。多变量分析显示,男性(59.8%比 47.6%,p=0.02;OR=1.78,95%CI 1.15-2.75)和年龄(平均±标准差 66.7±13.1 比 61.0±14.7 岁,p<0.001;OR=1.03,95%CI 1.01-1.05)与 VF 显著相关。与对照组相比,血液透析患者的主动脉 VC 发生率明显更高(80.6%比 68.4%,p=0.001)。除房颤外,与 VC 相关性最强的因素是血清 25(OH)维生素 D 水平低于 29ng/mL 与主动脉 VC(OR=1.85,95%CI 1.04-3.29)和 VF (OR=1.77,95%CI 1.00-3.14)以及髂骨 VC(OR=1.96,95%CI 1.27-3.04)均相关。总之,血液透析患者,尤其是男性,以及男女两性的 VC 发生率均较高。VF 与 VC 相关。维生素 D 缺乏也与 VC 相关。需要进一步的纵向研究来调查肾脏患者的骨折情况。

相似文献

1
High prevalence of vertebral fractures assessed by quantitative morphometry in hemodialysis patients, strongly associated with vascular calcifications.血液透析患者中通过定量形态计量学评估的椎体骨折高发率与血管钙化密切相关。
Calcif Tissue Int. 2013 Jul;93(1):39-47. doi: 10.1007/s00223-013-9722-x. Epub 2013 Mar 14.
2
Vitamin K, vertebral fractures, vascular calcifications, and mortality: VItamin K Italian (VIKI) dialysis study.维生素 K、椎体骨折、血管钙化和死亡率:意大利维生素 K(VIKI)透析研究。
J Bone Miner Res. 2012 Nov;27(11):2271-8. doi: 10.1002/jbmr.1677.
3
Atrial fibrillation and low vitamin D levels are associated with severe vascular calcifications in hemodialysis patients.心房颤动和低维生素D水平与血液透析患者的严重血管钙化有关。
J Nephrol. 2016 Jun;29(3):419-426. doi: 10.1007/s40620-015-0236-7. Epub 2015 Oct 22.
4
The Vessels-Bone Axis: Iliac Artery Calcifications, Vertebral Fractures and Vitamin K from VIKI Study.血管-骨骼轴:VIKI 研究中的髂动脉钙化、椎体骨折和维生素 K。
Nutrients. 2021 Oct 12;13(10):3567. doi: 10.3390/nu13103567.
5
Oral Calcitriol Use, Vertebral Fractures, and Vitamin K in Hemodialysis Patients: A Cross-Sectional Study.口服骨化三醇的应用、椎体骨折与血液透析患者的维生素 K:一项横断面研究。
J Bone Miner Res. 2021 Dec;36(12):2361-2370. doi: 10.1002/jbmr.4440. Epub 2021 Oct 8.
6
The relationship between the Spine Deformity Index, biochemical parameters of bone metabolism and vascular calcifications: results from the Epidemiological VERtebral FRACtures iTalian Study (EVERFRACT) in dialysis patients.脊柱畸形指数、骨代谢生化参数与血管钙化之间的关系:意大利透析患者流行病学椎体骨折研究(EVERFRACT)的结果
Clin Chem Lab Med. 2014 Nov;52(11):1595-603. doi: 10.1515/cclm-2014-0194.
7
[Prevalence of vertebral fractures and aortic calcifications in hemodialysis patients: comparison with a population of the same age and sex].血液透析患者椎体骨折和主动脉钙化的患病率:与相同年龄和性别的人群比较
Nefrologia. 2003;23 Suppl 2:106-11.
8
Prevalence of vertebral fractures, vascular calcifications, and mortality in warfarin treated hemodialysis patients.华法林治疗的血液透析患者中椎体骨折、血管钙化及死亡率的患病率
Curr Vasc Pharmacol. 2015;13(2):248-58. doi: 10.2174/15701611113119990146.
9
Vitamin D deficiency and associated factors in hemodialysis patients.血液透析患者的维生素D缺乏及其相关因素
J Ren Nutr. 2008 Sep;18(5):395-9. doi: 10.1053/j.jrn.2008.04.003.
10
Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease.慢性肾脏病中血管钙化、动脉僵硬度与骨矿物质密度之间的关联
Nephrol Dial Transplant. 2008 Feb;23(2):586-93. doi: 10.1093/ndt/gfm660. Epub 2007 Oct 12.

引用本文的文献

1
Lower serum magnesium levels are associated with a higher risk of fractures and vascular calcifications in hemodialysis patients.较低的血清镁水平与血液透析患者骨折和血管钙化的较高风险相关。
Clin Kidney J. 2024 Nov 28;18(1):sfae381. doi: 10.1093/ckj/sfae381. eCollection 2025 Jan.
2
Vertebral fractures in patients with CKD and the general population: a call for diagnosis and action.慢性肾脏病患者与普通人群中的椎体骨折:呼吁诊断与行动。
Clin Kidney J. 2024 Jul 9;17(8):sfae191. doi: 10.1093/ckj/sfae191. eCollection 2024 Aug.
3
Ten tips on how to assess bone health in patients with chronic kidney disease.
关于如何评估慢性肾病患者骨骼健康的十点建议。
Clin Kidney J. 2024 Apr 15;17(5):sfae093. doi: 10.1093/ckj/sfae093. eCollection 2024 May.
4
Real-world usage of Chronic Kidney Disease - Mineral Bone Disorder (CKD-MBD) biomarkers in nephrology practices.慢性肾脏病 - 矿物质和骨异常(CKD-MBD)生物标志物在肾脏病诊疗实践中的实际应用。
Clin Kidney J. 2023 Nov 29;17(1):sfad290. doi: 10.1093/ckj/sfad290. eCollection 2024 Jan.
5
Bone mineral density after exercise training in patients with chronic kidney disease stages 3 to 5: a sub-study of RENEXC-a randomized controlled trial.3至5期慢性肾脏病患者运动训练后的骨矿物质密度:RENEXC随机对照试验的一项子研究
Clin Kidney J. 2023 Nov 21;17(1):sfad287. doi: 10.1093/ckj/sfad287. eCollection 2024 Jan.
6
Serum phosphate is associated with increased risk of bone fragility fractures in haemodialysis patients.血清磷酸盐与血液透析患者脆性骨折风险增加相关。
Nephrol Dial Transplant. 2024 Mar 27;39(4):618-626. doi: 10.1093/ndt/gfad190.
7
Incidence of bone fractures among patients on maintenance hemodialysis.维持性血液透析患者骨折的发生率。
Ren Fail. 2023 Dec;45(1):2224456. doi: 10.1080/0886022X.2023.2224456.
8
Efficacy of vitamin K on bone fragility: puzzling findings from which we should learn how to design a rigorous study.维生素K对骨脆性的功效:令人困惑的发现,我们应从中学习如何设计一项严谨的研究。
Nephrol Dial Transplant. 2023 Sep 29;38(10):2105-2108. doi: 10.1093/ndt/gfad117.
9
Consensus Evidence-Based Clinical Practice Recommendations for the Diagnosis and Treat-To-Target Management of Osteoporosis in Chronic Kidney Disease Stages G4-G5D and Post-transplantation: An Initiative of Egyptian Academy of Bone Health.慢性肾脏病G4-G5D期及移植后骨质疏松症诊断与达标治疗的基于证据的临床实践共识推荐:埃及骨健康学会倡议
Kidney Dis (Basel). 2022 Oct 31;8(5):392-407. doi: 10.1159/000526492. eCollection 2022 Nov.
10
Management of osteoporosis in patients with chronic kidney disease.慢性肾脏病患者骨质疏松症的管理。
Osteoporos Int. 2022 Nov;33(11):2259-2274. doi: 10.1007/s00198-022-06462-3. Epub 2022 Jun 24.